Skip to main content

Use of Tyrosine Kinase Inhibitors (TKIs)

    Basic Details
    Date Posted
    Tuesday, February 27, 2018
    Status
    Complete
    Medical Product
    axitinib
    pazopanib
    sorafenib
    sunitinib
    tyrosine kinase inhibitor
    Description

    These reports contain baseline characteristics of patients receiving four types of tyrosine kinase inhibitors (TKIs) in the Sentinel Distributed Database (SDD). This request was distributed to 16 Data Partners on August 23, 2016; this report contains data from 16 Data Partners.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2006 - September 30, 2015
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    Individuals 18 years of age and older
    Data Sources
    Sentinel Distributed Database (SDD)